Starling Oncology, Inc. Goodwill, Impaired, Accumulated Impairment Loss
Starling Oncology, Inc. (DFPH) had Goodwill, Impaired, Accumulated Impairment Loss of $26.18 million as of 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Notes › Goodwill and Other › Goodwill, Impaired, Accumulated Impairment Loss
us-gaap:GoodwillImpairedAccumulatedImpairmentLoss · last filed 2026-03-12
- 2025-12-31: Goodwill, Impaired, Accumulated Impairment Loss $26.18M.
- 2024-12-31: Goodwill, Impaired, Accumulated Impairment Loss $26.18M.
- 2023-12-31: Goodwill, Impaired, Accumulated Impairment Loss $26.18M; Goodwill, Impaired, Accumulated Impairment Loss as first filed $16.87M.
- 2023-09-30: Goodwill, Impaired, Accumulated Impairment Loss $16.87M.
| Period end | Goodwill, Impaired, Accumulated Impairment Loss | Goodwill, Impaired, Accumulated Impairment Loss as first filed |
|---|---|---|
| 2025-12-31 | $26.18M 10-K · filed 2026-03-12 | |
| 2024-12-31 | $26.18M 10-K · filed 2026-03-12 | |
| 2023-12-31 | $26.18M 10-K · filed 2025-03-26 | $16.87M 10-K · filed 2024-03-28 |
| 2023-09-30 | $16.87M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $16.87M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $16.87M 10-Q · filed 2023-05-10 | |
| 2023-01-01 | $9.94M 10-K · filed 2025-03-26 | |
| 2022-12-31 | $9.94M 10-K · filed 2024-03-28 | |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $0.00 10-K · filed 2023-03-16 | |
| 2020-12-31 | $0.00 10-K · filed 2022-03-11 |